The use of biologic adjuvants in orthopedic injuries continues to expand along with the comprehension of the healing and regeneration mechanisms of tissues. Biological treatments represent a potentially attractive option for a number of hip disorders and include a variety of cell therapies and blood derived products, such as mesenchymal stem cells, bone marrow aspirate concentrate, matrix-induced autologous chondrocyte implantation, platelet rich plasma and others. Clinical studies have reported promising results and emerging basic studies have provided a clearer understanding of the underlying mechanisms of action of biologics in orthopedics. However, crucial questions remain regarding their indications, limitations, and overall efficacy. This review focuses on the current state of the use of biologics to improve outcomes in hip preservation surgery.
- femoroacetabular impingement
- preservation surgery